These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 36270140)

  • 1. Interaction of new VV-hemorphin-5 analogues with cell membrane models.
    Vitkova V; Staneva G; Hazarosova R; Georgieva SI; Valkova I; Antonova K; Todorov P
    Colloids Surf B Biointerfaces; 2022 Dec; 220():112896. PubMed ID: 36270140
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Valorphins alter physicochemical characteristics of phosphatidylcholine membranes: Datasets on lipid packing, bending rigidity, specific electrical capacitance, dipole potential, vesicle size.
    Vitkova V; Staneva G; Hazarosova R; Georgieva SI; Valkova I; Antonova K; Todorov P
    Data Brief; 2022 Dec; 45():108716. PubMed ID: 36426033
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antinociceptive Effects of VV-Hemorphin-5 Peptide Analogues Containing Amino phosphonate Moiety in Mouse Formalin Model of Pain.
    Assenov B; Pechlivanova D; Dzhambazova E; Peneva P; Todorov P
    Protein Pept Lett; 2021; 28(4):442-449. PubMed ID: 32798365
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anticonvulsant evaluation and docking analysis of VV-Hemorphin-5 analogues.
    Todorov P; Rangelov M; Peneva P; Todorova N; Tchekalarova J
    Drug Dev Res; 2019 Jun; 80(4):425-437. PubMed ID: 30681179
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Potential anticonvulsant activity of novel VV-hemorphin-7 analogues containing unnatural amino acids: synthesis and characterization.
    Todorov P; Peneva P; Tchekalarova J; Georgieva S
    Amino Acids; 2020 Apr; 52(4):567-585. PubMed ID: 32206933
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis, characterization and nociceptive screening of new VV-hemorphin-5 analogues.
    Todorov P; Peneva P; Pechlivanova D; Georgieva S; Dzhambazova E
    Bioorg Med Chem Lett; 2018 Oct; 28(18):3073-3079. PubMed ID: 30078474
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Family of hemorphins: co-relations between amino acid sequences and effects in cell cultures.
    Blishchenko EY; Sazonova OV; Kalinina OA; Yatskin ON; Philippova MM; Surovoy AY; Karelin AA; Ivanov VT
    Peptides; 2002 May; 23(5):903-10. PubMed ID: 12084521
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Investigation of the structure-activity relationship in a series of new LVV- and VV-hemorphin-7 analogues designed as potential anticonvulsant agents.
    Todorov P; Georgieva S; Peneva P; Tchekalarova J
    Amino Acids; 2022 Feb; 54(2):261-275. PubMed ID: 34978007
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis, characterization and anticonvulsant activity of new series of N-modified analogues of VV-hemorphin-5 with aminophosphonate moiety.
    Todorov P; Peneva P; Tchekalarova J; Rangelov M; Georgieva S; Todorova N
    Amino Acids; 2019 Nov; 51(10-12):1527-1545. PubMed ID: 31576456
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cathepsin D is a good candidate for the specific release of a stable hemorphin from hemoglobin in vivo: VV-hemorphin-7.
    Fruitier I; Garreau I; Piot JM
    Biochem Biophys Res Commun; 1998 May; 246(3):719-24. PubMed ID: 9618278
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Radioligand binding properties of VV-hemorphin 7, an atypical opioid peptide.
    Szikra J; Benyhe S; Orosz G; Darula Z; Piot JM; Fruitier I; Monory K; Hanoune J; Borsodi A
    Biochem Biophys Res Commun; 2001 Mar; 281(3):670-7. PubMed ID: 11237710
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis, characterization and anticonvulsant activity of new azobenzene-containing VV-hemorphin-5 bio photoswitch.
    Todorov PT; Peneva PN; Georgieva SI; Tchekalarova J; Vitkova V; Antonova K; Georgiev A
    Amino Acids; 2019 Mar; 51(3):549-563. PubMed ID: 30604096
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Kinetic of in vitro generation of some hemorphins: early release of LVV-hemorphin-7, precursor of VV-hemorphin-7.
    Dagouassat N; Garreau I; Zhao Q; Sannier F; Piot JM
    Neuropeptides; 1996 Feb; 30(1):1-5. PubMed ID: 8868292
    [TBL] [Abstract][Full Text] [Related]  

  • 14. LVV- and VV-hemorphins: comparative levels in rat tissues.
    Yatskin ON; Philippova MM; Blishchenko EYu ; Karelin AA; Ivanov VT
    FEBS Lett; 1998 May; 428(3):286-90. PubMed ID: 9654150
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structure-activity relationship study on new hemorphin-4 analogues containing steric restricted amino acids moiety for evaluation of their anticonvulsant activity.
    Todorov P; Peneva P; Tchekalarova J; Georgieva S; Rangelov M; Todorova N
    Amino Acids; 2020 Oct; 52(10):1375-1390. PubMed ID: 33011823
    [TBL] [Abstract][Full Text] [Related]  

  • 16. VV-hemorphin-7 and LVV-hemorphin-7 released during in vitro peptic hemoglobin hydrolysis are morphinomimetic peptides.
    Garreau I; Zhao Q; Pejoan C; Cupo A; Piot JM
    Neuropeptides; 1995 Apr; 28(4):243-50. PubMed ID: 7596489
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nonpolar interactions between trans-membrane helical EGF peptide and phosphatidylcholines, sphingomyelins and cholesterol. Molecular dynamics simulation studies.
    Róg T; Murzyn K; Karttunen M; Pasenkiewicz-Gierula M
    J Pept Sci; 2008 Apr; 14(4):374-82. PubMed ID: 17985365
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Generation of VV-hemorphin-7 from globin by peritoneal macrophages.
    Dagouassat N; Garreau I; Sannier F; Zhao Q; Piot JM
    FEBS Lett; 1996 Mar; 382(1-2):37-42. PubMed ID: 8612760
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Investigation of inhibition angiotensin-converting enzyme (ACE) activity and opioid activity of two hemorphins, LVV-hemorphin-5 and VV-hemorphin-5, isolated from a defined peptic hydrolysate of bovine hemoglobin.
    Zhao Q; Piot JM
    Neuropeptides; 1997 Apr; 31(2):147-53. PubMed ID: 9179868
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Kinetic studies on aminopeptidase M-mediated degradation of human hemorphin LVV-H7 and its N-terminally truncated products.
    John H; John S; Forssmann WG
    J Pept Sci; 2008 Jul; 14(7):797-803. PubMed ID: 18236385
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.